IELTS Academic Practice Test 25

Writing systems developed independently in several regions of the world, most notably Mesopotamia, Egypt, China, and Mesoamerica, over a period spanning several millennia. Despite arising in isolation from one another, these systems shared a common developmental trajectory, typically beginning with pictographic symbols representing concrete objects before gradually evolving towards more abstract representations capable of conveying complex ideas, grammatical relationships, and eventually sounds rather than meanings alone. The earliest known writing system, cuneiform, emerged in ancient Sumer around the late fourth millennium BCE, initially developed for practical administrative purposes rather than literary or religious expression. Archaeological evidence suggests early cuneiform tablets primarily recorded economic transactions, such as quantities of grain or livestock, reflecting the increasingly complex administrative needs of expanding urban settlements that could no longer rely solely on memory and oral tradition to track resources and obligations. Over subsequent centuries, cuneiform evolved considerably, transitioning from purely pictographic symbols towards a more abstract system combining logograms, symbols representing whole words or concepts, with phonetic elements representing syllabic sounds. This hybrid approach, balancing symbolic and phonetic representation, characterised many early writing systems and allowed scribes to represent an increasingly wide range of concepts, including abstract ideas and proper names, that would have been difficult or impossible to convey through purely pictographic representation alone. The eventual development of fully phonetic alphabets, in which a limited set of symbols represents individual sounds rather than whole words or syllables, represented a further significant simplification. The earliest alphabetic systems are generally traced to the Levant region around the early second millennium BCE, likely influenced by simplified Egyptian hieroglyphic symbols adapted to represent Semitic language sounds. This alphabetic principle, requiring learners to master only a small number of symbols rather than the hundreds or thousands required by logographic systems, is widely credited with dramatically expanding literacy beyond the small class of professional scribes who had previously monopolised writing in societies using more complex systems. Notably, not all writing systems followed this trajectory towards full alphabetic simplification. Chinese writing, for instance, retained a predominantly logographic structure throughout its long history, with individual characters generally representing whole words or morphemes rather than isolated sounds. Linguists continue to debate why some writing systems evolved towards phonetic simplification while others retained greater logographic complexity, with explanations ranging from linguistic structural differences between language families to cultural and political factors that shaped how each writing tradition developed over time.

Microplastics, generally defined as plastic fragments smaller than five millimetres in size, have emerged over the past two decades as a subject of intensive scientific research and growing public concern. These particles originate from multiple sources, including the gradual fragmentation of larger plastic debris exposed to sunlight and physical weathering, synthetic fibres shed from clothing during washing, and microbeads once commonly added to cosmetic products before regulatory bans in several countries. Research has established that microplastics are now essentially ubiquitous throughout global environments, detected in ocean water at virtually every depth studied, in freshwater lakes and rivers far from obvious pollution sources, in agricultural soils, and even in remote polar ice cores, suggesting atmospheric transport mechanisms carry particles far beyond their points of origin. Perhaps most strikingly, microplastics have been detected in numerous food and beverage products intended for human consumption, including seafood, salt, drinking water, and even beer, alongside detection in human blood and lung tissue in preliminary studies. The precise health implications of microplastic exposure in humans remain an area of active and, at present, somewhat inconclusive research. While laboratory studies using animal models have documented various physiological effects following high-dose microplastic exposure, translating these findings to realistic human exposure levels and timeframes presents substantial methodological challenges. Researchers generally caution against premature conclusions while simultaneously arguing that the precautionary principle warrants continued investigation and, where reasonably practical, exposure reduction, given the plausible biological mechanisms by which microplastics or the chemical additives they often contain could pose health risks. Ecological impacts, while similarly complex, appear somewhat better documented. Marine organisms across multiple trophic levels have been observed ingesting microplastics, sometimes mistaking particles for food, with documented effects including digestive tract blockage, reduced feeding efficiency, and, in some studied species, reduced reproductive success. Given microplastics' capacity to adsorb other environmental pollutants onto their surfaces, some researchers argue their ecological significance may extend beyond direct physical effects to include their role as vectors for other contaminants entering food webs. Addressing microplastic pollution presents unique challenges compared with larger plastic debris, given the practical near-impossibility of removing particles once dispersed throughout the environment. Consequently, most policy responses have focused on prevention rather than remediation, including regulations restricting microbead use in cosmetics, filters designed to capture synthetic fibres during washing machine cycles, and broader efforts to reduce overall plastic production and improve waste management infrastructure to limit the fragmentation of larger plastic items into microplastic particles in the first place.

The placebo effect, the phenomenon whereby patients experience genuine physiological or psychological improvement following treatment with an inert substance or sham procedure, has long presented a challenge to conventional understandings of medical treatment efficacy. Far from being a mere curiosity confined to clinical trial methodology, contemporary research increasingly suggests the placebo effect reflects genuine, measurable neurobiological processes with meaningful implications for how medicine is practised and understood. Randomised controlled trials, the methodological gold standard for evaluating medical treatments, typically compare an active treatment against a placebo precisely because placebo responses are often substantial enough to meaningfully confound assessment of a treatment's true effectiveness if left unaccounted for. Pain conditions, in particular, tend to show pronounced placebo responses, with some studies finding that a meaningful proportion of patients receiving inert treatments report significant symptom improvement, sometimes comparable in magnitude to active medications, particularly for subjective symptoms such as pain intensity rather than objectively measurable physiological markers. Neuroimaging research has begun illuminating the biological mechanisms underlying these responses. Studies employing brain scanning technology have demonstrated that placebo administration for pain can trigger measurable release of endogenous opioids, the body's own naturally produced pain-relieving compounds, alongside detectable changes in activity within brain regions associated with pain processing and expectation. This suggests the placebo effect, rather than representing mere patient suggestibility or a purely psychological phenomenon disconnected from physical reality, involves genuine neurochemical changes triggered by expectation and context. Interestingly, research has identified numerous contextual factors that influence placebo response magnitude, including the perceived cost of treatment, the confidence and warmth conveyed by treating clinicians, and even the colour and size of placebo pills themselves, with some studies finding that larger pills and certain colours are associated with stronger placebo responses for particular conditions. Perhaps most surprisingly, several studies have documented meaningful placebo responses even when patients were explicitly informed they were receiving an inert placebo, a finding that challenges the long-held assumption that placebo effects necessarily depend on patient deception. These findings raise complex ethical and practical questions for medical practice. Some researchers have proposed that clinicians might ethically harness placebo mechanisms, for instance through the manner in which treatments are communicated and administered, to enhance genuine treatment outcomes without resorting to deception. Others caution that formally incorporating placebo mechanisms into standard practice risks blurring important ethical boundaries around informed consent, suggesting that further research and careful ethical deliberation will be required before findings from placebo research meaningfully reshape everyday clinical practice.